Your email has been successfully added to our mailing list.

×
0.000578985167587931 0.00020204528818938 -0.00367967745523284 -0.000508834381988776 -0.000910857646415072 -0.000695857203321124 0.0029563939133374 0.00140604776951502
Stock impact report

Lilly Canada remains steadfast in commitment to access options for patients amidst controversial CDA-AMC recommendation for Ebglyss™ (lebrikizumab) [Yahoo! Finance]

Eli Lilly and Company (LLY) 
Last eli lilly and company earnings: 4/23 06:25 am Check Earnings Report
US:NYSE Investor Relations: investor.lilly.com
Company Research Source: Yahoo! Finance
Final Recommendation for Ebglyss™ (lebrikizumab), published on Friday, November 15, 2024 . The CDA-AMC recommended that Ebglyss not be reimbursed by public drug plans, excluding Quebec , for the treatment of moderate-to-severe atopic dermatitis (AD) in adults and adolescents 12 years of age and older. Lilly Canada stands behind Ebglyss as a first-line biological therapy for the treatment of atopic dermatitis and we remain committed to patients. Access to Ebglyss for new and existing patients with moderate-to-severe AD via LillyPlus ® will not change as we tenaciously pursue options for private and public reimbursement in Canada . We have shared our concerns with the CDA-AMC leadership and believe that the CDA-AMC are applying differential standards to biologic therapies for the treatment of AD that are not founded upon their own requirements. Lilly Canada continues to explore all options to overcome this recommendation. "CDA-AMC's recommendation is inconsistent with all other HTA Show less Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for LLY alerts
Opt-in for
LLY alerts

from News Quantified
Opt-in for
LLY alerts

from News Quantified